Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin

Abstract

The study has shown that the creatinine-based niosomes developed in our laboratory were biocompatible, safe and increased the oral bioavailability of the model hydrophobic Clarithromycin using experimental animals.